Common Stock, Shares, Outstanding of Can-Fite BioPharma Ltd. from 31 Dec 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • Can-Fite BioPharma Ltd. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 3,967,407,393, a 137% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 3,967,407,393 +2,295,678,900 +137% 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q4 2024 2,983,181,793 +1,623,344,400 +119% 31 Dec 2024 6-K 28 Aug 2025 2025 Q2
Q2 2024 1,671,728,493 +446,891,100 +36% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 1,359,837,393 +544,091,100 +67% 31 Dec 2023 20-F 14 Apr 2025 2024 FY
Q2 2023 1,224,837,393 +409,091,100 +50% 30 Jun 2023 6-K 31 Aug 2023 2023 Q2
Q4 2022 815,746,293 0 0% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 815,746,293 +300,000,000 +58% 30 Jun 2022 6-K 25 Aug 2022 2022 Q2
Q4 2021 815,746,293 +351,976,830 +76% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 515,746,293 +104,491,830 +25% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 463,769,463 +343,116,780 +284% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q2 2020 411,254,463 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q4 2019 120,652,683 +80,253,393 +199% 31 Dec 2019 20-F 25 Mar 2021 2020 FY
Q4 2018 40,399,290 31 Dec 2018 6-K 01 Jun 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.